SUMMARY The presence of cytomegalovirus (CMV) was analysed in either lymph node or skin and lung tissue necropsy specimens affected by Kaposi's sarcoma, from 10 patients who had died of AIDS. The different detection techniques used were: (i) immunohistochemical demonstration of CMV immediate early antigen (IEA); (ii) in situ hybridisation with a biotinylated CMV DNA probe; (iii) Southern blot hybridisation of DNA extracted from sequential tissue sections; and (iv) polymerase chain reaction (PCR) with CMV specific primers on the DNA samples. The results of these analyses were compared with the postmortem data on CMV obtained by infectious particle assays and histological examination, especially of adrenal glands of the same patients.
Human cytomegalovirus (CMV) is found in about 90% of patients with acquired immune deficiency syndrome (AIDS) and is one of the major causes of death of these patients.' CMV infection is most frequently observed in their adrenal glands.'2 The primary target for CMV in man seems to be epithelial and endothelial cells. subsot of Kaposi's sarcoma samples (15-20%) contained CMV DNA sequences, which in some cases were derived from occasional productively infected cells. 6 It was concluded that a causative role for CMV in Kaposi's sarcoma was questionable.
Accepted for publication 6 October 1988 A few years ago an in vitro DNA amplification technique was described by Saiki and coworkers.8 This so-called polymerase chain reaction (PCR) permits a 100 000-fold amplification of specific DNA sequences in a given sample using a heat stable DNA polymerase,9 synthetic oligonucleotide primers of specified base sequence, and a regimen of repeated cycles of denaturation, primer annealing, and primer extension. The PCR technique has been successfully used for the amplification of human89 and viral'0" DNA sequences from complex mixtures with a highly increased sensitivity compared with standard filter hybridisation techniques.
We used four independent techniques including PCR for the detection of CMV "footprints" in tissues of patients with AIDS with variable incidence of Kaposi's sarcoma and compared the results of these analyses with those of histological examination of adrenal glands and virus culture assays. To 
Results
The table shows the data on the detection of CMV in the different tissue sections. Immunohistochemical detection of CMV IEA was successful in the lymph node of case 3 in a few solitary cells outside the region with Kaposi's sarcoma and in the lymph node ofcase 6 in which no Kaposi's sarcoma was present. In situ hybridisation with biotinylated total CMV genome as probe detected solitary CMV infected cells in the lymph nodes ofcases 3 and 6 and in the lung ofcase 10.
No morphologically normal cells with small inclusion bodies'5 suggestive ofearly stages ofinfection or latent CMV genomes were found.
To be able to correlate Southern blot and PCR data directly with IEA and in situ hybridisation results on cryostat sections, tissue DNA was prepared from sequential sections from the same tissue blocks. Southern blot hybridisation was performed on EcoRI digested tissue DNAs using the CMV EcoRI J fragment as probe which detects a 10 kilobase CMV specific band. Control hybridisations were performed with the pXE6-2 plasmid" containing a 9 5 kilobase insert which spans the HSV-2 BgIIN fragment. Only in case 10 (lung) and case 6 was a 10 kilobase band detected with the CMV probe; the results with the HSV-2 probe were negative in all patients analysed. PCR analysis proved its potential by detecting a CMV specific 147 base pair band in the tissue DNAs ofsix patients (cases 2, 3, 6, 7, 8 and 10-both lung and skin), the strongest signal was found in the lung of case 10.
Discussion
Comparison of different CMV detection techniques (table) shows that with respect to sensitivity of detection histological examination of adrenal gland tissue and PCR analysis seem to be the methods of choice (six of 10 patients), closely followed by the infectious particle assay (five of 10); in two cases culture results were unreliable because of microbial contamination. Southern blotting seems to be the least sensitive (two of 10), although two potentially positive tissues could not be analysed because of low DNA yield; still it was the only technique which was negative in case 3. In situ hybridisation with the total CMV genome as probe scored intermediate (four of 12); one case was dubious because ofthe presence ofonly one apparently positive cell while all other techniques in this patient (case 5) do not detect CMV. Although unlikely, this finding may be genuine because of sample variation in case of low numbers of infected cells. Although we used a larger biotinylated in situ hybridisation probe (100% of the CMV genome compared with 17%) than Grody and coworkers,7 we were unable to detect CMV in spindlelike Kaposi's sarcoma cells.7
Immunohistochemical IEA detection gave clear results in two of 12 tissues. Actually we considered in situ hybridisation and IEA detection to be of similar sensitivity because both techniques in our hands stained the same number of CMV positive cells in massively infected adrenal glands of patients with AIDS which we routinely use as positive controls (data not shown '5) . As a consequence ofthe detection system used, which also detects persistent endogenous peroxidase activity in some macrophages and granulocytes despite the inactivation step. Immunohistochemistry results on frozen sections must be interpreted extra carefully and proper control incubations should be included for each section.
The table shows that the results of CMV detection obtained with the different methods correlated very well. The only inconsistency seemed to be case 9 who had a positive CMV culture but was negative in all further analyses. This patient may have had an early stage of CMV infection in the trachea without spread to other organs. The apparent lower detection efficiency with in situ hybridisation and IEA compared with that of virus culture and PCR may reflect the fact that the latter techniques cover a much larger amount of(homogenised) tissue. This implies that the presence of only a small number of infected cells in each tissue block is easily missed in the few sections that are used for in situ hybridisation and IEA detection.
The conclusion that CMV infection seems unrelated to the development of Kaposi's sarcoma in patients with AIDS emerges from the results presented in the table. Because only hybridisation probes and PCR primers were used from the EcoRI J fragment of the CMV (AD169) genome, however, the presence of other parts of the CMV genome in the sarcoma cells would have been missed in the Southern blot and PCR experiments. The results of the in situ hybridisation experiments, which in our hands detect about 100 kilobase pairs of complementary DNA sequences per cell in model experiments (data not shown) and which used the complete CMV genome as probe,'5 suggest that less than 50% of the CMV genome must have been present in each Kaposi's sarcoma cell. Moreover, the EcoRI J fragment may contain part of the transforming gene(s) of CMV," which implies that the persistence of integrated copies of CMV-transforming genes in the sarcoma nuclei would have been detected by Southern blotting in cases where more than 10% of the cells were Kaposi's sarcoma cells (cases 1, 2, 4, 7-10). We cannot exclude the possibility that a small hitherto unidentified transforming fragment of CMV is responsible for the induction of Kaposi's sarcoma in some patients with AIDS. The fact remains, however, that Kaposi's sarcoma also occurs in patients without traces of CMV infection ( 
